Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Unknown 3 Terminated 2 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Sarcoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thymus Neoplasms 1 Sarcoma, Synovial 1 Prostatic Neoplasms 1 Multiple Myeloma 1 Mesothelioma 1 Meningioma 1 Melanoma 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Fatigue 1 Dermatofibrosarcoma 1 Cardiovascular Diseases 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Bone Neoplasms 1 Adenocarcinoma 1

Interventions

Fulvestrant 58 Trastuzumab 49 Capecitabine 48 Letrozole 45 pembrolizumab 41 Carboplatin 41 Paclitaxel 39 Cyclophosphamide 38 ribociclib 37 pertuzumab 36 abemaciclib 36 Blood Specimen Collection 31 Specimen Handling 28 trastuzumab deruxtecan 27 Docetaxel 27 Surveys and Questionnaires 26 Anastrozole 25 exemestane 24 Tamoxifen 24 palbociclib 21 130-nm albumin-bound paclitaxel 21 Magnetic Resonance Spectroscopy 20 Biopsy 19 sacituzumab govitecan 18 eribulin 18 Radiotherapy 18 Gemcitabine 18 olaparib 17 Injections 17 Epirubicin 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Breast Neoplasms × Quality of Life × Clear all

NCT06648278 2026-01-13

COUNTS2

University of California, San Francisco

Phase NA Recruiting

Breast Neoplasms, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡